BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8874872)

  • 1. Opiate withdrawal increases ProTRH gene expression in the ventrolateral column of the midbrain periaqueductal gray.
    Légrádi G; Rand WM; Hitz S; Nillni EA; Jackson IM; Lechan RM
    Brain Res; 1996 Aug; 729(1):10-19. PubMed ID: 8874872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of precipitated morphine withdrawal on post-translational processing of prothyrotropin releasing hormone (proTRH) in the ventrolateral column of the midbrain periaqueductal gray.
    Nillni EA; Lee A; Legradi G; Lechan RM
    J Neurochem; 2002 Mar; 80(5):874-84. PubMed ID: 11948251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efferent projections of ProTRH neurons in the ventrolateral periaqueductal gray.
    Mihaly E; Legradi G; Fekete C; Lechan RM
    Brain Res; 2001 Nov; 919(2):185-97. PubMed ID: 11701131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of preproenkephalin mRNA in the caudal part of periaqueductal gray by morphine withdrawal in rats: a quantitative in situ hybridization study.
    Fukunaga Y; Nishida S; Inoue N; Kishioka S; Yamamoto H
    Brain Res Mol Brain Res; 1996 Nov; 42(1):128-30. PubMed ID: 8915589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprothyrotropin-releasing hormone mRNA in the rat central gray is strongly and persistently induced during morphine withdrawal.
    Gahn LG; Sevarino KA
    Neuropeptides; 1996 Jun; 30(3):207-12. PubMed ID: 8819143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla.
    Bellchambers CE; Chieng B; Keay KA; Christie MJ
    Neuroscience; 1998 Mar; 83(2):517-24. PubMed ID: 9460759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats.
    Hao S; Liu S; Zheng X; Zheng W; Ouyang H; Mata M; Fink DJ
    Neuropsychopharmacology; 2011 Feb; 36(3):664-76. PubMed ID: 21068718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of morphine withdrawal and preproenkephalin gene expression in the periaqueductal gray of rats.
    Fukunaga Y; Nishida S; Inoue N; Miyamoto M; Kishioka S; Yamamoto H
    Brain Res Mol Brain Res; 1998 Apr; 55(2):221-31. PubMed ID: 9582424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurons containing a N-terminal sequence of the TRH-prohormone (preproTRH53-74) are present in a unique location of the midbrain periaqueductal gray of the rat.
    Van den Bergh P; Wu P; Jackson IM; Lechan RM
    Brain Res; 1988 Sep; 461(1):53-63. PubMed ID: 3147123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of minocycline into the periaqueductal gray attenuates morphine withdrawal signs.
    Liu Q; Tang S; Du X; Sun Y; Lai J; Wang X
    Neurosci Lett; 2020 Sep; 736():135283. PubMed ID: 32739271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal.
    Chieng B; Keay KA; Christie MJ
    Neurosci Lett; 1995 Jan; 183(1-2):79-82. PubMed ID: 7746492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced c-Fos in periaqueductal grey GABAergic neurons during opioid withdrawal.
    Chieng BC; Hallberg C; Nyberg FJ; Christie MJ
    Neuroreport; 2005 Aug; 16(12):1279-83. PubMed ID: 16056125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Fos activation in the periaqueductal gray following acute morphine-3β-D-glucuronide or morphine administration.
    Arout CA; Caldwell M; McCloskey DP; Kest B
    Physiol Behav; 2014 May; 130():28-33. PubMed ID: 24631297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
    Lane DA; Patel PA; Morgan MM
    Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
    Jones KL; Barr GA
    Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist.
    Walters CL; Aston-Jones G; Druhan JP
    Neuropsychopharmacology; 2000 Sep; 23(3):307-15. PubMed ID: 10942854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
    Hack SP; Vaughan CW; Christie MJ
    Neuropharmacology; 2003 Oct; 45(5):575-84. PubMed ID: 12941371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.
    McPhie AA; Barr GA
    Dev Psychobiol; 2009 Nov; 51(7):544-52. PubMed ID: 19708041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal from progesterone increases expression of alpha4, beta1, and delta GABA(A) receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats.
    Griffiths J; Lovick T
    J Comp Neurol; 2005 May; 486(1):89-97. PubMed ID: 15834956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal.
    Iredale PA; Alvaro JD; Lee Y; Terwilliger R; Chen YL; Duman RS
    J Neurochem; 2000 Jan; 74(1):199-208. PubMed ID: 10617121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.